Covalent Partners’s Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share FSNB.WS Stock Holding History

Covalent Partners’s Portfolio FSNB.WS Stock Details FSNB.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,000	Closed	-$1K	–	64
2022 Q1	$1K	Hold	4,000	–	–	﹤0.01%	59
2021 Q4	$2K	Hold	4,000	–	–	﹤0.01%	63
2021 Q3	$3K	Hold	4,000	–	–	0.01%	53
2021 Q2	$4K	Buy	+4,000	New	+$3.15K	﹤0.01%	58

Other funds holding FSNB.WS

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Ramius Advisors New York $95.2M AUM 7.33% 1-Year Est. Return

Covalent Partners's FSNB.WS Position: Q2 2022 in Review

Covalent Partners sold out of Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share (FSNB.WS) in Q2 2022, closing a stake of 4,000 shares — an estimated $1K sold.

Covalent Partners first reported a position in FSNB.WS in Q2 2021 and held it in 4 quarters. The position peaked at $4K in Q2 2021. 72 funds tracked by Wall St. Rank hold FSNB.WS as of Q2 2022.

Covalent Partners reported no remaining Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position as of Q2 2022 after selling out during the quarter.
Covalent Partners sold 4,000 Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share shares in Q2 2022, an estimated $1K.
Covalent Partners first reported a position in Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share in Q2 2021 and held it in 4 quarters.
Covalent Partners's Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position peaked at $4K in Q2 2021.
72 funds tracked by Wall St. Rank held Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share as of Q2 2022.

Based on Covalent Partners's 13F filing for Q2 2022, filed 15 Aug 2022.